Related Experiment Videos
Vasoactive intestinal polypeptide and the canine cerebral circulation
Circulation Research
|January 1, 1981
Summary
Vasoactive intestinal polypeptide (VIP) increases blood flow in some vessels but does not affect overall cerebral blood flow (CBF). Local VIP release may influence CBF, but it
Area of Science:
- Neuroscience
- Vascular Biology
- Pharmacology
Background:
- Cerebrovascular nerves containing vasoactive intestinal polypeptide (VIP) may influence cerebral blood flow (CBF).
- The role of VIP in regulating CBF during physiological challenges like hypercapnia and hypoxia is not fully understood.
Purpose of the Study:
- To investigate the role of VIP in cerebrovascular regulation.
- To determine if VIP affects CBF during hypercapnia and hypoxia.
- To explore the mechanisms by which VIP influences cerebral circulation.
Main Methods:
- Measurements of CBF using cerebral venous outflow and microsphere methods in anesthetized dogs.
- Radioimmunoassay to measure plasma VIP concentrations.
- Intra-arterial and intraventricular administration of VIP to assess its effects on CBF and regional cerebral blood flow (rCBF).
Main Results:
- Hypercapnia and hypoxia increased cerebral venous outflow but did not alter VIP concentrations in arterial blood, cerebral venous blood, or cerebrospinal fluid (CSF).
- Intra-arterial VIP increased blood flow in the common carotid artery and temporalis muscle but had no effect on total or regional CBF.
- Unilateral intraventricular infusion of VIP significantly increased rCBF, suggesting a local effect within the brain.
Conclusions:
- Local release of VIP from perivascular nerve endings may influence CBF.
- The blood-brain barrier likely contributes to the unresponsiveness of canine cerebral vessels to blood-borne VIP.
- VIP does not appear to mediate CBF changes induced by hypercapnia or hypoxia.